In vivo metabolic imaging of mouse tumor models in response to chemotherapy

The aim of the study was to estimate energy metabolism in human cervical cancer cells HeLa Kyoto after chemotherapy in vitro and in vivo using two-photon fluorescence lifetime microscopy (FLIM). Cellular metabolism was examined by monitoring of the fluorescence intensities and lifetimes of metabolic cofactors NAD(P)H and FAD. Cancer metabolism was analyzed in dynamics after treatment with cisplatin. Two-photon fluorescence and second harmonic generation microscopies as well as standard histopathology with hematoxylin and eosin were used to characterize cancer tissue structure. We showed an increase of the optical redox ratio FAD/NAD(P)H in cancer cells in vitro and decrease of the relative contribution of free NAD(P)H (ɑ1) in vitro and in vivo, which presumably indicate a shift to more oxidative metabolism after chemotherapy. These data demonstrate the possibility to detect response of cancer cells to chemotherapy using optical metabolic imaging.

[1]  F. J. Corpas,et al.  NADPH-generating dehydrogenases: their role in the mechanism of protection against nitro-oxidative stress induced by adverse environmental conditions , 2014, Front. Environ. Sci..

[2]  A. J. Bain,et al.  Separating NADH and NADPH fluorescence in live cells and tissues using FLIM , 2014, Nature Communications.

[3]  M. Mehta,et al.  Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy. , 1991, International journal of radiation oncology, biology, physics.

[4]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[5]  Irene Georgakoudi,et al.  Optical spectroscopy and imaging for the noninvasive evaluation of engineered tissues. , 2008, Tissue engineering. Part B, Reviews.

[6]  Paolo Dell’ Antone,et al.  Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects? , 2012 .

[7]  Jens Eickhoff,et al.  In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia. , 2007, Journal of biomedical optics.

[8]  Pierre Guerreschi,et al.  Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics , 2015, International journal of cell biology.

[9]  Sung Soo Kim,et al.  Cancer cell metabolism: implications for therapeutic targets , 2013, Experimental & Molecular Medicine.

[10]  Melissa C. Skala,et al.  Drug response in organoids generated from frozen primary tumor tissues , 2016, Scientific Reports.

[11]  D. Winge,et al.  Emerging concepts in the flavinylation of succinate dehydrogenase. , 2013, Biochimica et biophysica acta.

[12]  P. French,et al.  Wide-field fluorescence lifetime imaging of cancer , 2010, Biomedical optics express.

[13]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[14]  Guillem Pratx,et al.  Imaging metabolic heterogeneity in cancer , 2016, Molecular Cancer.

[15]  Amy T. Shah,et al.  Optical Metabolic Imaging of Treatment Response in Human Head and Neck Squamous Cell Carcinoma , 2014, PloS one.

[16]  N. Ramanujam,et al.  In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia , 2007, Proceedings of the National Academy of Sciences.

[17]  Amy T. Shah,et al.  In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment , 2015, Neoplasia.

[18]  Stefan Wölfl,et al.  Real-Time Monitoring of Cisplatin-Induced Cell Death , 2011, PloS one.

[19]  Jie Zheng,et al.  Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). , 2012, Oncology letters.

[20]  M. Rigoulet,et al.  The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. , 2011, Biochimica et biophysica acta.

[21]  Andrew D. Southam,et al.  Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics , 2016, Metabolomics.